Antiretroviral Current Events | Antiretroviral News | 5
|
| Page
5 of
8 |
156 Results |
|
|
|
Sort By:
Page Views | Date |
HIV infection appears to increases the risk of heart attack
Researchers from Massachusetts General Hospital (MGH) have found that infection with HIV, the virus that causes AIDS, is also associated with increased risk of myocardial infarction or heart attack. view more (2007-04-25)
Gene therapy shows promise as weapon against HIV
A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV. view more (2009-02-23)
Injection of synthetic polymer may improve facial wasting syndrome associated with HIV
Facial injections of polylactic acid, a synthetic biodegradable polymer, may help improve the debilitating facial lipoatrophy (loss of fat in the face) associated with HIV infection and its treatment. view more (2006-03-21)
HIV vaccine takes different tack to boosting immune response
esearchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection. view more (2006-01-03)
Nurses safely and effectively prescribe antiretroviral drugs in pilot program
Given sufficient training and support, nurses can safely and effectively prescribe antiretroviral therapy (ART) to patients with HIV, according to a Rwandan study published in this week's PLoS Medicine. view more (2009-10-13)
Viral 'fitness' explains different resistance patterns to aids drugs
Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. view more (2006-01-11)
Catching the blood cell bus gives fatal yeast infection a clean getaway
Yeast fungus cells that kill thousands of AIDS patients every year escape detection by our bodies' defences by hiding inside our own defence cells, and hitch a ride through our systems before attacking and spreading, scientists heard today (Tuesday 9 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at... view more... (2008-09-09)
Anti-HIV drug has potential to prevent transmission in women
A new study from infectious disease researchers at The Miriam Hospital and Brown Medical School finds that a drug already given orally to treat HIV is also safe when applied as a vaginal microbicide gel. view more (2006-02-10)
AIDS-related cognitive impairment exists in two separate forms
Cognitive impairment in people with AIDS exists in two forms - one mild, another severe - each affecting different areas of the brain. view more (2006-04-06)
International HIV/AIDS trial finds risks increase on episodic antiretroviral therapy
Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. view more (2006-11-30)
Delay in use of nevirapine-based AIDS treatment can improve outcomes
Delaying the use of nevirapine-containing antiretroviral therapy (ART) for at least six months after labor may improve treatment outcomes among HIV-infected women in developing countries who took nevirapine during labor to prevent their babies from becoming infected, suggests a new study in The New England Journal of Medicine. view more (2007-01-11)
Maternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding. view more (2009-10-19)
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Further evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission (pp 842, 859)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. A follow-up study among mothers with HIV-1 and their infants in this week's issue of THE LANCET provides further evidence for the sustained efficacy of nevirapine as a low-cost option to help prevent vertical HIV-1 transmission from mothers to newborn children in... view more... (2003-09-10)
New Stanford list of HIV mutations vital to tracking AIDS epidemic
In a collaborative study with the World Health Organization and seven other laboratories, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends throughout the world. view more (2009-03-06)
The release of new data from the HVTN 502 HIV vaccine study
The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were more HIV infections in the vaccinees as compared... view more... (2007-11-08)
Fat on chest and upper back increases risk of insulin resistance
Upper trunk fat -- deposits of fat on the chest and back -- is associated with an increased risk of insulin resistance, a condition that is a precursor of type 2 diabetes, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC). view more (2007-08-20)
Immune response to HIV in the brain
Using multi-disciplinary analysis that included cognitive, neurophysiologic, virologic, and molecular techniques, the team found both a low-level viral infection in the brain and immune cells that had infiltrated the brain in order to protect against the virus. view more (2006-04-28)
Landmark study defines benefits of early HIV testing and treatment for infected infants
Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. view more (2008-11-20)
HIV patients have increased risk of pneumonia, death following surgery
HIV-infected patients undergoing surgical procedures may be more likely to develop pneumonia after surgery and to die within 12 months than those without HIV, according to a report in the December issue of Archives of Surgery, one of the JAMA/Archives journals. view more (2006-12-19)
|
|
| Page
5 of
8 |
156 Results |
|
|
|
Sort By:
Page Views | Date |
|
